Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12524)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2023 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 2023; 29(8): 1243-1260 [PMID: 36925456 DOI: 10.3748/wjg.v29.i8.1243] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i8/1243.htm |
| Number | Citing Articles |
| 1 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(552) |
Core Tip(539) |
Full Article(HTML)(2300)
|
Full Article with Cover (PDF)-3548K(151)
|
Full Article (Word)-242K(24)
|
Audio-234K(13)
|
Peer-Review Report-224K(99)
|
Answering Reviewers-264K(80)
|
Full Article (PDF)-550K(147)
|
Full Article (XML)-38K(75)
|
Times Cited (3)
|
Total Visits (5996)
|
Open
|
| 2 |
Abdullah Altaf, Yutaka Endo, Muhammad M. Munir, Muhammad Muntazir M. Khan, Zayed Rashid, Mujtaba Khalil, Alfredo Guglielmi, Francesca Ratti, Hugo Marques, François Cauchy, Vincent Lam, George Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Tom Hugh, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB 2024; 26(8): 1040 doi: 10.1016/j.hpb.2024.05.006
|
| 3 |
Zhanao He, Jie Zhang, Wukui Huang. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47560-4
|
| 4 |
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn. Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2024; 16(15): 2652 doi: 10.3390/cancers16152652
|
| 5 |
Shenyu Zhang, Guibin Yang, Ruipeng Song, Wei Wang, Fanzheng Meng, Dalong Yin, Jiabei Wang, Shugeng Zhang, Wei Cai, Yao Liu, Dayong Luo, Jizhou Wang, Lianxin Liu. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241258394
|
| 6 |
Okjoo Lee, Jaehong Jeong, So Kyung Yoon, Jun Chul Chung, Jongman Kim, Kwang-Woong Lee, Hyung Chul Kim. Association of primary hepatocellular carcinoma laterality with oncological outcomes for hepatic resection patients: A retrospective, multicenter, propensity score-matched study. Asian Journal of Surgery 2025; doi: 10.1016/j.asjsur.2024.12.065
|
| 7 |
Kunpeng Cao, Liuxi Wu, Xinyue Wang, Hongyan Deng, Ya Yuan, Lu Li, Chaoli Xu, Xinhua Ye. Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241281327
|
| 8 |
Longxing Wang, Zhiming Zhao, Kunxian Shu, Mingyue Ma. MPCD Index for Hepatocellular Carcinoma Patients Based on Mitochondrial Function and Cell Death Patterns. International Journal of Molecular Sciences 2024; 26(1): 118 doi: 10.3390/ijms26010118
|
| 9 |
Da Guo, Liping Liu, Yu Jin. Prediction early recurrence of hepatocellular carcinoma after hepatectomy using gadoxetic acid-enhanced MRI and IVIM. European Journal of Radiology Open 2025; 14: 100643 doi: 10.1016/j.ejro.2025.100643
|
| 10 |
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot. α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk. Gastro Hep Advances 2024; 3(3): 316 doi: 10.1016/j.gastha.2023.11.018
|
| 11 |
Xiaokun Chen, Xiangan Wu, Wei Peng, Liguo Liu, Xiao Liu, Xueshuai Wan, Haifeng Xu, Yongchang Zheng, Haitao Zhao, Yilei Mao, Xin Lu, Xinting Sang, Xiaoyan Chang, Kang Zhou, Jie Pan, Mei Guan, Dandan Hu, Haidong Tan, Yaojun Zhang, Shunda Du. Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study. Journal of Hepatocellular Carcinoma 2025; : 561 doi: 10.2147/JHC.S504016
|
| 12 |
Xinru Wen, Xianling Wang, Qing Yao, Simin Chen, Chengwei Li, Congyang Zheng, Ang Huang, Xiaoyan Zhan, Zhaofang Bai, Xiaohe Xiao. Hypericin impedes M2 macrophage polarization and protects against Hepatocellular carcinoma. Molecular Immunology 2025; 181: 160 doi: 10.1016/j.molimm.2025.03.012
|
| 13 |
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. 2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed <i>Baishideng</i> journals. World Journal of Gastroenterology 2024; 30(1): 9-16 doi: 10.3748/wjg.v30.i1.9
Abstract(596) |
Core Tip(583) |
Full Article(HTML)(2613)
|
Full Article with Cover (PDF)-2263K(105)
|
Full Article (Word)-406K(22)
|
Audio-1093K(12)
|
Peer-Review Report-215K(85)
|
Answering Reviewers-70K(84)
|
Full Article (PDF)-843K(132)
|
Full Article (XML)-66K(78)
|
Times Cited (1)
|
Total Visits (6849)
|
Open
|
| 14 |
Xinxin Wang, Yanyan Yu, Yuqing Tao, Yueqi Wang, Chunhui Zhang, Yali Cui, Yang Zhou. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients. Journal of Hepatocellular Carcinoma 2023; : 2323 doi: 10.2147/JHC.S434955
|
| 15 |
Yuan Tian, Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Bei Li, Geng Liu. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12162-4
|
| 16 |
Chaowen Xiao, Xinyang Zhao, Zouxiao Hu, Guanbao Long. MFSD2A Overexpression Inhibits Hepatocellular Carcinoma Through TGF‐β/Smad Signaling. Molecular Carcinogenesis 2025; 64(3): 597 doi: 10.1002/mc.23875
|
| 17 |
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, Inmaculada Castelló-Miralles, Moisés Diago. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(19): 2512-2522 doi: 10.3748/wjg.v30.i19.2512
|
| 18 |
Yuanyue Guan, Jiaxi Li, Bin Sun, Kaikun Xu, Yonghong Zhang, Haijing Ben, Yingmei Feng, Mengcheng Liu, Shanshan Wang, Yuxue Gao, Zhongping Duan, Yang Zhang, Dexi Chen, Yanjun Wang. HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S/Smad/TGF-β1 loop. International Journal of Biological Macromolecules 2024; 281: 136327 doi: 10.1016/j.ijbiomac.2024.136327
|
| 19 |
Francesco Vasuri, Stefano Chillotti, Thais Maloberti, Elisa Albertini, Giuliana Germinario, Matteo Cescon, Matteo Ravaioli, Dario de Biase, Antonia D’Errico. Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. Virchows Archiv 2025; 486(2): 365 doi: 10.1007/s00428-024-03791-y
|
| 20 |
Matheus D. Faleiro, Zuhaib M. Mir, Yara Azizieh, Stephanie E. Hiebert, Scott M. Livingstone, Mark J. Walsh, Boris L. Gala-Lopez. Oncologic Outcomes of Interventions to Decrease Allograft Ischemia-Reperfusion Injury within Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review. Current Oncology 2024; 31(6): 2895 doi: 10.3390/curroncol31060221
|
| 21 |
Meng Fan. Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer. American Journal of Cancer Research 2024; 14(8): 3922 doi: 10.62347/PAYM2267
|
| 22 |
Parissa Tabrizian, Adriana Pero, Myron Schwartz. Hepatic Resection for Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 59 doi: 10.1016/j.cld.2024.08.008
|
| 23 |
Dongkai Gao, Zumo Zhou, Lin Chen, Jun Zheng, Jinna Yang. CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/ Wnt/β-Catenin signaling axis. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13808-7
|
| 24 |
Bing-Bing Su, Chao-Jie Zhu, Jun Cao, Rui Peng, Dao-Yuan Tu, Guo-Qing Jiang, Sheng-Jie Jin, Qian Wang, Chi Zhang, Dou-Sheng Bai. Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models. Surgical Endoscopy 2025; 39(4): 2540 doi: 10.1007/s00464-025-11631-6
|
| 25 |
Chunhong Tian, Yifan Yu, Yuqing Wang, Lunwei Yang, Ying Tang, Chengyang Yu, Gaofei Feng, Dayong Zheng, Xiongwen Wang. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352873
|
| 26 |
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
|
| 27 |
Rex Wan-Hin Hui, Keith Wan-Hang Chiu, I-Cheng Lee, Chenlu Wang, Ho-Ming Cheng, Jianliang Lu, Xianhua Mao, Sarah Yu, Lok-Ka Lam, Lung-Yi Mak, Tan-To Cheung, Nam-Hung Chia, Chin-Cheung Cheung, Wai-Kuen Kan, Tiffany Cho-Lam Wong, Albert Chi-Yan Chan, Yi-Hsiang Huang, Man-Fung Yuen, Philip Leung-Ho Yu, Wai-Kay Seto. Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery. Hepatology 2024; doi: 10.1097/HEP.0000000000001180
|
| 28 |
Zhi-Jun Zhang, Ba-Jin Wei, Zhi-Kun Liu, Ze-Feng Xuan, Lin Zhou, Shu-Sen Zheng. Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection. Hepatobiliary & Pancreatic Diseases International 2024; doi: 10.1016/j.hbpd.2024.09.006
|
| 29 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(713) |
Core Tip(687) |
Full Article(HTML)(3649)
|
Full Article with Cover (PDF)-1825K(208)
|
Full Article (Word)-130K(37)
|
Audio-14227K(22)
|
Peer-Review Report-222K(86)
|
Answering Reviewers-194K(66)
|
Full Article (PDF)-407K(192)
|
Full Article (XML)-119K(90)
|
Times Cited (0)
|
Total Visits (10944)
|
Open
|
| 30 |
Andreea-Elena Scheau, Sandra Oana Jurca, Cristian Scheau, Ioana Gabriela Lupescu. Non-Surgical Treatment for Hepatocellular Carcinoma: What to Expect at Follow-Up Magnetic Resonance Imaging—A Pictorial Review. Applied Sciences 2024; 14(20): 9159 doi: 10.3390/app14209159
|
| 31 |
Jiahao Li, Yingnan Liu, Yuqi Qiu, Chao Qu, Jiarui Li. Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1487353
|
| 32 |
Meilin Yang, Xiaoyi Song, Fan Zhang, Mingan Li, Wuguang Chang, Zheyan Wang, Man Li, Hong Shan, Dan Li. Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse. Hepatology 2024; doi: 10.1097/HEP.0000000000000979
|
| 33 |
Ye Lu, Huanhuan Wang, Chenxia Li, Ferdos Faghihkhorasani, Cheng Guo, Xin Zheng, Tao Song, Qingguang Liu, Shaoshan Han. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(9): 108476 doi: 10.1016/j.ejso.2024.108476
|
| 34 |
Sen Wang, Ying Zhao, Jiayi Li, Zongmin Yi, Jun Li, Can Zuo, Yu Yao, Ailian Liu. Self-supervised multi-modal feature fusion for predicting early recurrence of hepatocellular carcinoma. Computerized Medical Imaging and Graphics 2024; 118: 102457 doi: 10.1016/j.compmedimag.2024.102457
|
| 35 |
Jusen Nong, Kejian Yang, Tianman Li, Chenlu Lan, Xin Zhou, Junqi Liu, Haixiang Xie, Jianzhu Luo, Xiwen Liao, Guangzhi Zhu, Tao Peng. SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma. Aging 2023; 15(16): 8408 doi: 10.18632/aging.204978
|
| 36 |
Wei Shen, Lebin Yuan, Fei Cheng, Zhao Wu, Xiaodong Li. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration. Genes & Genomics 2024; 46(1): 49 doi: 10.1007/s13258-023-01463-w
|
| 37 |
Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu. Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma. Journal of Korean Medical Science 2024; 39(37) doi: 10.3346/jkms.2024.39.e251
|
| 38 |
Jin Sun. Dystrobrevin beta is a promising prognostic biomarker and therapeutic target for hepatocellular carcinoma. American Journal of Translational Research 2024; 16(10): 6072 doi: 10.62347/FCFO5076
|
| 39 |
Han Shi, Caixia Hu. A prediction model based on machine learning: prognosis of HBV-induced HCC male patients with smoking and drinking habits after local ablation treatment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1464863
|
| 40 |
Priya Acharya, Cecilia Calnan, Afaf Girgis, Miriam Tania Levy. ‘I need to know, just put me in the picture’: a qualitative study of the lived experiences and supportive care needs of patients with hepatocellular carcinoma. Frontline Gastroenterology 2025; 16(2): 137 doi: 10.1136/flgastro-2024-102796
|
| 41 |
Mohammad SS Naviwala, Waqas A Khan, Adeeba Zaki, Mahnoor Tariq, Faiza Ahmed, Warda Saleem, Munira Moosajee, Yasmin A Rashid. Overall Survival and the Impact of Albumin-bilirubin Grade in Patients with Advanced Hepatocellular Carcinoma: Data from a Tertiary Care Hospital in a Lower-middle-income Country. Euroasian journal of hepato-gastroenterology 2024; 14(2): 251 doi: 10.5005/jp-journals-10018-1447
|
| 42 |
LINGLI ZHANG, YAN LI, JINGXIN MAO. Research progress on natural products against hepatocellular carcinoma. BIOCELL 2024; 48(6): 905 doi: 10.32604/biocell.2024.050396
|
| 43 |
Yang Haishen, Feiyu Jiang, Xinxin Si, Dan Sun, Haoran Fei, Dali Wang, Kai Li, Shengwang Du, Wei Hu, Zhong Wang. Expression of ALG8 in hepatocellular carcinoma and its diagnostic and prognostic significance. Scandinavian Journal of Gastroenterology 2025; 60(1): 62 doi: 10.1080/00365521.2024.2433562
|
| 44 |
Shiye Yang, Haishun Ni, Aixian Zhang, Jixiang Zhang, Hong Zang, Zhibing Ming. Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-85020-9
|
| 45 |
Yutaka Endo, Muhammad Musaab Munir, Selamawit Woldesenbet, Erryk Katayama, Francesca Ratti, Hugo P Marques, François Cauchy, Vincent Lam, George A Poultsides, Minoru Kitago, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score. Annals of Surgical Oncology 2023; 30(11): 6581 doi: 10.1245/s10434-023-13825-5
|
| 46 |
JiaYi Li, Yinxin Wu, Dingyin Zhang, Ziyan Zhang, Songqiang Li, Xi Cheng, Lihan Chen, Gang Zhou, Chengfu Yuan. The Roles of Cytoplasmic Polyadenylation Element Binding Protein 1 in Tumorigenesis. Mini-Reviews in Medicinal Chemistry 2024; 24(22): 2008 doi: 10.2174/0113895575293544240605112838
|
| 47 |
Ji Zhang, Qing Chen, Yu Zhang, Jie Zhou. Construction of a random survival forest model based on a machine learning algorithm to predict early recurrence after hepatectomy for adult hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13366-4
|
| 48 |
Jae Hyun Kwon, Eun-Kyoung Jwa, Jong Woo Lee, Eunyoung Tak, Shin Hwang. Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92500-z
|
| 49 |
Mariana Michelle Ramírez-Mejía, Nahum Méndez-Sánchez. From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring. World Journal of Gastroenterology 2024; 30(7): 631-635 doi: 10.3748/wjg.v30.i7.631
Abstract(529) |
Core Tip(524) |
Full Article(HTML)(2309)
|
Full Article with Cover (PDF)-5085K(139)
|
Full Article (Word)-521K(29)
|
Audio-645K(7)
|
Peer-Review Report-227K(76)
|
Answering Reviewers-80K(73)
|
Full Article (PDF)-1079K(130)
|
Full Article (XML)-71K(70)
|
Times Cited (0)
|
Total Visits (5022)
|
Open
|
| 50 |
Zhirong Zhang, Jiayao Yang, Rui Liu, Jing Ma, Kai Wang, Xiaojun Wang, Ni Tang. Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling. Genes & Diseases 2024; 11(5): 101285 doi: 10.1016/j.gendis.2024.101285
|
| 51 |
Qi Fan, Pengcheng Wei, Delin Ma, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study. Surgery Open Science 2025; 23: 16 doi: 10.1016/j.sopen.2024.12.004
|
| 52 |
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation. Meditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
|
| 53 |
Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05760-z
|
| 54 |
Rokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, Allan Rasmusson, Dovile Zilenaite-Petrulaitiene, Kestutis Strupas, Arvydas Laurinavicius, Aiste Gulla. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria. Current Oncology 2024; 31(9): 5344 doi: 10.3390/curroncol31090394
|
| 55 |
Qingchen Meng, Xiaohang Li, Hongxin Lang. Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: a Systematic Review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1559491
|
| 56 |
Yusra Zarlashat, Hassan Mushtaq, Linh Pham, Wasim Abbas, Keisaku Sato. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies. International Journal of Molecular Sciences 2024; 25(13): 6830 doi: 10.3390/ijms25136830
|
| 57 |
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, Siyuan Deng, Xuzhen Zheng, Baiyu Ji, Xiangyang Wu, Yingzi Yu. CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96. Journal of Molecular Medicine 2025; 103(3): 285 doi: 10.1007/s00109-025-02515-2
|
| 58 |
Jiaojiao Zheng, Siying Wang, Lei Xia, Zhen Sun, Kui Ming Chan, René Bernards, Wenxin Qin, Jinhong Chen, Qiang Xia, Haojie Jin. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02075-w
|
| 59 |
Qian Ren, Yanjun Wang. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”. Annals of Surgical Oncology 2023; 30(13): 8023 doi: 10.1245/s10434-023-14444-w
|
| 60 |
Kunpeng Cao, Xinyue Wang, Chaoli Xu, Liuxi Wu, Lu Li, Ya Yuan, Xinhua Ye. Ultrasound-based Radiomics Analysis for Assessing Risk Factors Associated With Early Recurrence Following Surgical Resection of Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2024; 50(12): 1964 doi: 10.1016/j.ultrasmedbio.2024.09.002
|
| 61 |
Luca Ielasi, Enrico Fulco, Nicola Reggidori, Marco Domenicali, Francesco Giuseppe Foschi. Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights 2024; 15(3): 599 doi: 10.3390/gastroent15030044
|
| 62 |
Zheng Song, Yu Zhang, Wei Luo, Chao Sun, Caihong Lv, Sihao Wang, Quanwei He, Ran Xu, Zhaofang Bai, Xiujuan Chang, Yongping Yang. HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis. Current Cancer Drug Targets 2025; 25(2): 144 doi: 10.2174/0115680096279597240219055135
|
| 63 |
V. V. Petkau, R. I. Rasulov, A. A. Muratov, G. V. Nurbekyan, I. B. Uvarov, A. A. Kirshin, R. V. Orlova, N. V. Popova, M. S. Dinikin, R. Yu. Khlobystin, A. V. Sultanbaev, K. V. Menshikov, O. G. Orlov. Long-term results of surgical treatment of hepatocellular cancer in Russian real practice. Meditsinskiy sovet = Medical Council 2024; (21): 114 doi: 10.21518/ms2024-422
|
| 64 |
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction. Medicine 2023; 102(35): e34937 doi: 10.1097/MD.0000000000034937
|
| 65 |
Yubo Zhang, Hongyan Ma, Peng Lei, Zhiyuan Li, Zhao Yan, Xinqing Wang. Prediction of early postoperative recurrence of hepatocellular carcinoma by habitat analysis based on different sequence of contrast-enhanced CT. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1522501
|
| 66 |
Zhiyue Xie, Yanxia Wu, Nan Peng, Jing Wang, Hui Wang, Liang Zhao. BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression. Cancer Gene Therapy 2025; doi: 10.1038/s41417-025-00890-z
|
| 67 |
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen. Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1289916
|
| 68 |
Dan Chen, Ayinuer Aierken, Hui Li, Ruihua Chen, Lei Ren, Kai Wang. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1232390
|
| 69 |
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565: 119977 doi: 10.1016/j.cca.2024.119977
|
| 70 |
Tao Sun, Xiangkun Wang, Guangcan Zhu, Jinfu Zhang, Juan Huang, Renfeng Li, Xinguang Qiu. The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93716-9
|
| 71 |
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology 2023; 12(7): 984 doi: 10.3390/biology12070984
|
| 72 |
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang.
KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma
. Critical Reviews in Eukaryotic Gene Expression 2024; 34(4): 55 doi: 10.1615/CritRevEukaryotGeneExpr.2024051414
|
| 73 |
Mario Romeo, Marcello Dallio, Carmine Napolitano, Claudio Basile, Fiammetta Di Nardo, Paolo Vaia, Patrizia Iodice, Alessandro Federico. Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?. Diagnostics 2025; 15(3): 252 doi: 10.3390/diagnostics15030252
|
| 74 |
Guoqun Zheng, Minjie Zheng, Peng Hu, Yu Zhu, Wenlong Zhang, Fabiao Zhang. Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; : 539 doi: 10.2147/JHC.S510581
|
| 75 |
Hao Li, Lixue Qiao, Minyu Kong, Haoran Fang, Zhiping Yan, Ran Guo, Wenzhi Guo. Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78467-3
|
| 76 |
Honghai Zhang, Shugui Sheng, Wenying Qiao, Yu Sun, Ronghua Jin. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395329
|
| 77 |
Lingbo Hu, Xuemei Li, Changhong Yang, Baoyong Zhou, Chengyou Du, Ning Jiang. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1390938
|
| 78 |
Xi Wang, Xinqun Chai, Ji Zhang, Ruiya Tang, Qinjunjie Chen. Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12655-2
|
| 79 |
Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers 2025; 17(4): 566 doi: 10.3390/cancers17040566
|
| 80 |
Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis. Abdominal Radiology 2024; 49(10): 3397 doi: 10.1007/s00261-024-04356-y
|
| 81 |
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liver. HPB 2024; 26(5): 691 doi: 10.1016/j.hpb.2024.02.010
|
| 82 |
Kunyuan Jiang, Jingfei Li, Zihao Liu, Miao Chen, Wei Cai, Lianxin Liu, Dalong Yin. Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study. International Journal of Surgery 2025; 111(1): 857 doi: 10.1097/JS9.0000000000001879
|
| 83 |
Pei‐Chang Lee, Tsung‐Yi Cheng, Chun‐Ting Ho, Kuo‐Wei Huang, Gar‐Yang Chau, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su. Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical Resection. Liver International 2025; 45(2) doi: 10.1111/liv.16237
|
| 84 |
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102344 doi: 10.1016/j.clinre.2024.102344
|
| 85 |
Chang-Yi Lu, Kun-Feng Tsai, Chia-Jui Yen, Chueh-Jung Hsieh, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Chi-Jen Chu. Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01599-x
|
| 86 |
Jian-Hong Zhong. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World Journal of Gastroenterology 2024; 30(8): 806-810 doi: 10.3748/wjg.v30.i8.806
Abstract(527) |
Core Tip(527) |
Full Article(HTML)(2236)
|
Full Article with Cover (PDF)-818K(158)
|
Full Article (Word)-224K(15)
|
Audio-482K(8)
|
Peer-Review Report-171K(75)
|
Answering Reviewers-10K(68)
|
Full Article (PDF)-451K(160)
|
Full Article (XML)-71K(90)
|
Times Cited (4)
|
Total Visits (5159)
|
Open
|
| 87 |
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?. Cancers 2023; 15(11): 2950 doi: 10.3390/cancers15112950
|
| 88 |
Yanxing Mai, Zhuocheng Ji, Yujing Tan, Lei Feng, Jiasheng Qin. BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01592-y
|
| 89 |
Christian M. Schürch. Liver cancer recurrence predicted by immune-cell location and gene expression. Nature 2025; doi: 10.1038/d41586-025-00734-8
|
| 90 |
Xuehan Shen, Wei Yan, Erlei Zhang, Zhiwei Zhang, Zunyi Zhang, Hanhua Dong. Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02444-3
|
| 91 |
Belinda Sánchez-Pérez, José M Ramia. Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery?. World Journal of Gastrointestinal Oncology 2024; 16(2): 255-258 doi: 10.4251/wjgo.v16.i2.255
Abstract(455) |
Core Tip(449) |
Full Article(HTML)(1381)
|
Full Article with Cover (PDF)-627K(107)
|
Full Article (Word)-111K(15)
|
Audio-216K(26)
|
Peer-Review Report-171K(66)
|
Answering Reviewers-216K(83)
|
Full Article (PDF)-358K(110)
|
Full Article (XML)-58K(82)
|
Times Cited (1)
|
Total Visits (4234)
|
Open
|